Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
ALHC
|
Hyong Kim
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 16,506 Reduced 4.72% |
$352,403
$21.35 p/Share
|
Jan 06
2026 |
|
EW
|
Donald E Bobo Jr
CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct | 11,340 Reduced 26.24% |
$967,302
$85.3 p/Share
|
Jan 06
2026 |
|
SQ
|
Brian Grassadonia
Ecosystem Lead |
SELL
Open market or private sale
|
Direct | 1,983 Reduced 0.38% |
$135,875
$68.52 p/Share
|
Jan 06
2026 |
|
GPOR
|
Matthew Rucker
EVP & COO |
SELL
Open market or private sale
|
Direct | 10,732 Reduced 45.43% |
$1,999,586
$186.32 p/Share
|
Jan 06
2026 |
|
ACN
|
Joel Unruch
General Counsel/Corp Secretary |
SELL
Open market or private sale
|
Direct | 1,332 Reduced 4.51% |
$366,300
$275.0 p/Share
|
Jan 06
2026 |
|
YELP
|
Joseph R Nachman
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 7,000 Reduced 3.57% |
$233,380
$33.34 p/Share
|
Jan 06
2026 |
|
GALT
|
Joel Lewis
President and CEO |
SELL
Open market or private sale
|
Direct | 37,698 Reduced 4.33% |
$134,958
$3.58 p/Share
|
Jan 06
2026 |
|
PATH
|
Daniel Dines
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 45,000 Reduced 0.16% |
$719,550
$15.99 p/Share
|
Jan 06
2026 |
|
GALT
|
Khurram Jamil
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 21,446 Reduced 100.0% |
$78,277
$3.65 p/Share
|
Jan 06
2026 |
|
GALT
|
Jack W Callicutt
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 20,354 Reduced 72.78% |
$74,699
$3.67 p/Share
|
Jan 06
2026 |
|
LTBR
|
Sweta Chakraborty
Director |
SELL
Open market or private sale
|
Direct | 1,245 Reduced 2.48% |
$19,521
$15.68 p/Share
|
Jan 06
2026 |
|
UTHR
|
Christopher Causey |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 19.27% |
$510,000
$510.0 p/Share
|
Jan 06
2026 |
|
SCTC
|
Y.D. More Investments LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 650 Reduced 0.0% |
$2,119
$3.26 p/Share
|
Jan 05
2026 |
|
SYM
|
Todd Krasnow
Director |
SELL
Open market or private sale
|
Indirect | 4,000 Reduced 0.0% |
$272,840
$68.21 p/Share
|
Jan 05
2026 |
|
CDEV
|
John Charles Bell
EVP, General Counsel |
SELL
Open market or private sale
|
Direct | 70,249 Reduced 12.7% |
$966,626
$13.76 p/Share
|
Jan 05
2026 |
|
CDEV
|
William M Hickey Iii
Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 309,980 Reduced 17.34% |
$4,259,125
$13.74 p/Share
|
Jan 05
2026 |
|
CDEV
|
James H Walter
Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 310,003 Reduced 17.34% |
$4,259,441
$13.74 p/Share
|
Jan 05
2026 |
|
CDEV
|
Robert Regan Shannon
EVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 70,254 Reduced 13.07% |
$966,695
$13.76 p/Share
|
Jan 05
2026 |
|
CDEV
|
Guy M Oliphint
EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 128,837 Reduced 14.03% |
$1,772,797
$13.76 p/Share
|
Jan 05
2026 |
|
ABOS
|
Russell Barton
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 2.94% |
$7,840
$1.96 p/Share
|
Jan 05
2026 |
|
ABOS
|
Derek M Meisner
Chief Legal Officer & Corp Sec |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 2.48% |
$7,840
$1.96 p/Share
|
Jan 05
2026 |
|
ABOS
|
Daniel Joseph O Connell
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 4,649 Reduced 0.7% |
$9,158
$1.97 p/Share
|
Jan 05
2026 |
|
ABOS
|
Eric Siemers
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 2.35% |
$7,840
$1.96 p/Share
|
Jan 05
2026 |
|
ABOS
|
Matt Zuga
CFO & Chief Business Officer |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 1.73% |
$7,840
$1.96 p/Share
|
Jan 05
2026 |
|
SNAP
|
Evan Spiegel
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 1,220,165 Reduced 4.51% |
$10,066,361
$8.25 p/Share
|
Jan 05
2026 |
|
TECTP
|
A Haag Sherman
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 0.0% |
$114,000
$5.7 p/Share
|
Jan 05
2026 |
|
ADPT
|
Chad M Robins
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 124,998 Reduced 4.61% |
$1,948,718
$15.59 p/Share
|
Jan 05
2026 |
|
TECTP
|
Thomas R Sanders
Director |
SELL
Open market or private sale
|
Direct | 172,480 Reduced 80.19% |
$2,542,355
$14.74 p/Share
|
Jan 05
2026 |
|
ANTX
|
Stephen David Prior
Chief Strategy Officer |
SELL
Open market or private sale
|
Direct | 3,604 Reduced 5.5% |
$3,604
$1.0 p/Share
|
Jan 05
2026 |
|
ANTX
|
Lucy Day
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,295 Reduced 3.91% |
$3,295
$1.0 p/Share
|
Jan 05
2026 |
|
TECTP
|
Steven B Clapp
Director |
SELL
Open market or private sale
|
Direct | 172,480 Reduced 84.1% |
$2,542,355
$14.74 p/Share
|
Jan 05
2026 |
|
ANTX
|
Joshua M Eizen |
SELL
Open market or private sale
|
Direct | 17,923 Reduced 10.11% |
$17,923
$1.0 p/Share
|
Jan 05
2026 |
|
ANTX
|
Sanjay Chanda
Chief Development Officer |
SELL
Open market or private sale
|
Direct | 3,295 Reduced 3.87% |
$3,295
$1.0 p/Share
|
Jan 05
2026 |
|
PPTA
|
Chris J Robison
Director |
SELL
Open market or private sale
|
Direct | 10,201 Reduced 10.25% |
$267,674
$26.24 p/Share
|
Jan 05
2026 |
|
PPTA
|
Alexander Mc Leod Sternhell
Director |
SELL
Open market or private sale
|
Direct | 10,148 Reduced 34.4% |
$268,922
$26.5 p/Share
|
Jan 05
2026 |
|
CRWV
|
Brannin Mc Bee
Chief Development Officer |
SELL
Open market or private sale
|
Indirect | 27,000 Reduced 0.0% |
$2,169,180
$80.34 p/Share
|
Jan 05
2026 |
|
PPTA
|
Robert Alan Dean
Director |
SELL
Open market or private sale
|
Direct | 3,308 Reduced 11.81% |
$86,934
$26.28 p/Share
|
Jan 05
2026 |
|
CRWV
|
Brannin Mc Bee
Chief Development Officer |
SELL
Open market or private sale
|
Indirect | 8,835 Reduced 0.0% |
$710,864
$80.46 p/Share
|
Jan 05
2026 |
|
PPTA
|
Mckinsey Margaret Lyon
Officer |
SELL
Open market or private sale
|
Direct | 32,490 Reduced 25.16% |
$864,558
$26.61 p/Share
|
Jan 05
2026 |
|
DKL
|
Reuven Spiegel
Executive Vice President, DKL |
SELL
Open market or private sale
|
Direct | 250 Reduced 1.08% |
$11,747
$46.99 p/Share
|
Jan 05
2026 |
|
PPTA
|
Jeffrey L Malmen
Director |
SELL
Open market or private sale
|
Direct | 10,181 Reduced 34.51% |
$268,167
$26.34 p/Share
|
Jan 05
2026 |
|
CRWV
|
Brannin Mc Bee
Chief Development Officer |
SELL
Open market or private sale
|
Indirect | 28,000 Reduced 0.0% |
$2,252,880
$80.46 p/Share
|
Jan 05
2026 |
|
CRWV
|
Brannin Mc Bee
Chief Development Officer |
SELL
Open market or private sale
|
Direct | 102,835 Reduced 29.26% |
$8,304,954
$80.76 p/Share
|
Jan 05
2026 |
|
PLAB
|
Kang Jyh Lee |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 2.1% |
$339,000
$33.9 p/Share
|
Jan 05
2026 |
|
SEV
|
Michael Edious Johnson
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 10,500 Reduced 0.0% |
$48,299
$4.6 p/Share
|
Jan 05
2026 |
|
LPTH
|
North Run Strategic Opportunities Fund I, LP |
SELL
Open market or private sale
|
Indirect | 770,321 Reduced 0.0% |
$9,028,162
$11.72 p/Share
|
Jan 05
2026 |
|
CBLL
|
David Foehr
Senior VP, Finance and PAO |
SELL
Open market or private sale
|
Direct | 5,556 Reduced 22.72% |
$125,565
$22.6 p/Share
|
Jan 05
2026 |
|
CVX
|
Michael K Wirth
Chairman and CEO |
SELL
Open market or private sale
|
Direct | 320,700 Reduced 95.69% |
$52,395,966
$163.38 p/Share
|
Jan 05
2026 |
|
AXSM
|
Herriot Tabuteau
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 78,703 Reduced 91.59% |
$13,480,249
$171.28 p/Share
|
Jan 05
2026 |
|
WDAY
|
Carl M. Eschenbach
CEO |
SELL
Open market or private sale
|
Indirect | 3,125 Reduced 0.0% |
$656,250
$210.0 p/Share
|
Jan 05
2026 |